| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |